IFNGR1 and glioblastoma: Additionally, loss of genes in the IFN-γR signaling pathway (IFNGR1, JAK1, or JAK2) reduces overall CAR T cell binding duration and avidity in GBM, with other solid tumors being more resistant to CAR T cell-mediated death (38).